1 |
Tsuji, K., T. Aoki, E. Tejima, K. Arai, S. R. Lee, D. N. Atochin, P. L. Huang, X. Wang, J. Montaner and E. H. Lo. 2005. Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia. Stroke 36. 1954-1959.
DOI
ScienceOn
|
2 |
Verstraete, M. 2000. Third-generation thrombolytic drugs. Am. J. Med. 109. 52-58.
DOI
ScienceOn
|
3 |
Lo, E. H., T. Dalkara and M. A. Moskowitz. 2003 Mechanism, challenges and opportunites in stroke. Nat. Rev. Neurosci. 4. 399-415.
|
4 |
Rosenberg, G. A. 2002. Matrix metalloproteinase in neuroinflammation. Glia. 39. 279-291.
DOI
ScienceOn
|
5 |
Suzuki, Y., T. Kano, Y. Katayama, E. Tejima and T. Harada. 2003. Reduction of infarction volume by bolus injection of pamiteplase: a modified tissue plasminogen activator with longer half-life. Neurol. Res. 25. 477-480.
DOI
ScienceOn
|
6 |
Smalling, R. W. 1996. Molecular biology of plasminogen activators: what are the clinical implications of drug design. Am. J. Cardiol. 78. 2-7.
|
7 |
Sumii, T. and E. H. Lo. 2002. Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focalischemia in rat. Stroke 33. 831-836.
DOI
ScienceOn
|
8 |
Sumii, T., A. B. Singhal, M. Asahi, M. Suzuki, K. Miyata and E. H. Lo. 2001. Protective effects of pamiteplase, a modified tPA, in a rat model of embolic stroke. NeuroReport 12. 615-618.
DOI
ScienceOn
|
9 |
Tanswell, P., E. Seifried and P. C. S. 1989. Pharmacokinetics and systemic effects of tissue-type plasminogen activator in normal subjects. Clin. Pharmacol. Ther. 46, 155-162.
DOI
ScienceOn
|
10 |
Tejima, M., Y. Katayama, Y. Suzuki, T. Kano and E. H Lo. 2001. Hemorrhagic transformation after fibrinolysis with tissue plasminogen activator: Evalution of role of hypertension with rat thromboembolic stroke model. Stroke 32. 1336-1340.
DOI
ScienceOn
|
11 |
The national Institute for neurological disorders and stroke rtPA study group. 1995. N. Engl. J. Med. 333, 1581-1587.
DOI
ScienceOn
|
12 |
Lapchack, P. A., D. M. Arujo, S. Pakola, D. Song, J. Wei and J. A. Zivin. 2002. microplasrnin: a novel thrombolytic that improves behavioral outcome after embolic strokes in rabbits. Stroke 33. 2279-2284.
DOI
ScienceOn
|
13 |
del Zoppo, G. J. and T. Mabuchi. 2003. Cerebral microvessel responses to focal ischemia. J. Cereb. Blood Flow Metab. 23. 879-894.
DOI
|
14 |
Katoh, M. and K. Hayamizu. 2000. Research and development of novel modified tissue-type plasminogen activator (t-PA), pamiteplase. Nippon Yakurigaku Zasshi. 115. 237-243.
DOI
ScienceOn
|
15 |
Kawasaki, T., S. Kawamura, S. Katoh and T. T akenaka. 1993. Experimental model of carotid artery thrombosis in rats and the thrombolytic activity of YM866, a novel modified tissue-type plasminogen activator. Jpn. J. Pahrmacol. 63. 135-142.
DOI
|
16 |
Lee, S. R. 2006. Essential role for c-jun N-terminal kinase on tPA induced matrix metalloproteinase-9 regulation in rat astrocytes. Integrative Biosciences 10. 79-83.
과학기술학회마을
|